Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome
Overview
Authors
Affiliations
Steroid-sensitive nephrotic syndrome (SSNS) is a childhood disease with unclear pathophysiology and genetic architecture. We investigated the genomic basis of SSNS in children recruited in Europe and the biopsy-based North American NEPTUNE cohort. We performed three ancestry-matched, genome-wide association studies (GWAS) in 273 children with NS (Children Cohort Nephrosis and Virus [NEPHROVIR] cohort: 132 European, 56 African, and 85 Maghrebian) followed by independent replication in 112 European children, transethnic meta-analysis, and conditional analysis. GWAS alleles were used to perform glomerular -expression quantitative trait loci studies in 39 children in the NEPTUNE cohort and epidemiologic studies in GWAS and NEPTUNE (97 children) cohorts. Transethnic meta-analysis identified one SSNS-associated single-nucleotide polymorphism (SNP) rs1063348 in the 3' untranslated region of (=9.3×10). Conditional analysis identified two additional independent risk alleles upstream of (rs28366266, =3.7×10) and in the 3' untranslated region of (rs9348883, =9.4×10) within introns of and These three risk alleles were independent of the risk haplotype identified in European patients. Increased burden of risk alleles across independent loci was associated with higher odds of SSNS. Increased burden of risk alleles across independent loci was associated with higher odds of SSNS, with younger age of onset across all cohorts, and with increased odds of complete remission across histologies in NEPTUNE children. rs1063348 associated with decreased glomerular expression of HLA-DRB1, HLA-DRB5, and HLA-DQB1. Transethnic GWAS empowered discovery of three independent risk SNPs for pediatric SSNS. Characterization of these SNPs provide an entry for understanding immune dysregulation in NS and introducing a genomically defined classification.
Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies.
Horinouchi T, Nozu K, Iijima K Clin Exp Nephrol. 2025; .
PMID: 40085383 DOI: 10.1007/s10157-025-02645-4.
Emerging Role of SH3BP2 as Regulator of Immune and Nonimmune Cells in Nephrotic Syndrome.
Srivastava T, Sharma M Glomerular Dis. 2025; 5(1):1-12.
PMID: 39991193 PMC: 11842026. DOI: 10.1159/000542703.
Regalia A, Abinti M, Alfieri C, Campise M, Verdesca S, Zanoni F Clin Kidney J. 2024; 17(12):sfae320.
PMID: 39664990 PMC: 11630810. DOI: 10.1093/ckj/sfae320.
MicroRNAs in idiopathic childhood nephrotic syndrome.
Sinha A, Sra M, Ahmed A, Mallick S, Saini H, Devi K Clin Exp Nephrol. 2024; .
PMID: 39630311 DOI: 10.1007/s10157-024-02595-3.
Chan H, Ni F, Zhao B, Jiang H, Ding J, Wang L Genes Dis. 2024; 11(4):101126.
PMID: 38560502 PMC: 10978544. DOI: 10.1016/j.gendis.2023.101126.